Guanfacine Related Clinical Trials
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia [Active, not recruiting]
Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD) [Completed]
Guanfacine to Treat Borderline Personality Disorder [Recruiting]
Guanfacine Immediate-Release Thorough QTc Study [Recruiting]
Modeling Stress-Precipitated Smoking Behavior for Medication Development: Guanfacine [Recruiting]
SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms [Completed]
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder [Recruiting]
Guanfacine for Improving Cognitive Symptoms in People With Schizotypal Personality Disorder [Recruiting]
Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse [Recruiting]
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder [Completed]
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension [Recruiting]
Efficacy and Safety of SPD503 in Combination With Psychostimulants [Recruiting]
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [Completed]
Treatment of Supine Hypertension in Autonomic Failure [Recruiting]
The Role of Norepinephrine in Emotional Processing [Recruiting]
Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [Completed]
Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [Completed]
Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) [Completed]
Safety and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [Completed]
Stress and Medication Effects on Cocaine Cue Reactivity [Recruiting]
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts [Recruiting]
|
